These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
405 related articles for article (PubMed ID: 34180743)
1. How Has HIV Pre-Exposure Prophylaxis (PrEP) Changed Sex? A Review of Research in a New Era of Bio-behavioral HIV Prevention. Grov C; Westmoreland DA; D'Angelo AB; Pantalone DW J Sex Res; 2021 Sep; 58(7):891-913. PubMed ID: 34180743 [TBL] [Abstract][Full Text] [Related]
2. Same-day initiation of oral pre-exposure prophylaxis among gay, bisexual, and other cisgender men who have sex with men and transgender women in Brazil, Mexico, and Peru (ImPrEP): a prospective, single-arm, open-label, multicentre implementation study. Veloso VG; Cáceres CF; Hoagland B; Moreira RI; Vega-Ramírez H; Konda KA; Leite IC; Bautista-Arredondo S; Vinícius de Lacerda M; Valdez Madruga J; Farias A; Lima JN; Zonta R; Lauria L; Tamayo CVO; Flores HJS; Santa Cruz YMC; Aguayo RMM; Cunha M; Moreira J; Makkeda AR; Díaz S; Guanira JV; Vermandere H; Benedetti M; Ingold HL; Pimenta MC; Torres TS; Grinsztejn B; Lancet HIV; 2023 Feb; 10(2):e84-e96. PubMed ID: 36565708 [TBL] [Abstract][Full Text] [Related]
3. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis. Hugo JM; Stall RD; Rebe K; Egan JE; De Swardt G; Struthers H; McIntyre JA AIDS Behav; 2016 Dec; 20(Suppl 3):357-364. PubMed ID: 27631366 [TBL] [Abstract][Full Text] [Related]
4. On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial. Antoni G; Tremblay C; Delaugerre C; Charreau I; Cua E; Rojas Castro D; Raffi F; Chas J; Huleux T; Spire B; Capitant C; Cotte L; Meyer L; Molina JM; Lancet HIV; 2020 Feb; 7(2):e113-e120. PubMed ID: 31784343 [TBL] [Abstract][Full Text] [Related]
5. Cabotegravir Extended-Release Injectable Suspension: A Review in HIV-1 Pre-Exposure Prophylaxis. Blair HA Drugs; 2022 Sep; 82(14):1489-1498. PubMed ID: 36255686 [TBL] [Abstract][Full Text] [Related]
6. Pre-Exposure Prophylaxis for HIV Prevention in Women: Current Status and Future Directions. Hodges-Mameletzis I; Fonner VA; Dalal S; Mugo N; Msimanga-Radebe B; Baggaley R Drugs; 2019 Aug; 79(12):1263-1276. PubMed ID: 31309457 [TBL] [Abstract][Full Text] [Related]
7. Moderating Effect of Pre-Exposure Prophylaxis Use on the Association Between Sexual Risk Behavior and Perceived Risk of HIV Among Brazilian Gay, Bisexual, and Other Men Who Have Sex With Men: Cross-Sectional Study. Blair KJ; Torres TS; Hoagland B; Bezerra DRB; Veloso VG; Grinsztejn B; Clark J; Luz PM JMIR Public Health Surveill; 2023 Oct; 9():e45134. PubMed ID: 37796573 [TBL] [Abstract][Full Text] [Related]
8. Protocol for a multicenter, real-world study of HIV pre-exposure prophylaxis among men who have sex with men in China (CROPrEP). Wang H; Zhang Y; Mei Z; Jia Y; Leuba SI; Zhang J; Chu Z; Ding H; Jiang Y; Geng W; Shang H; Xu J BMC Infect Dis; 2019 Aug; 19(1):721. PubMed ID: 31416439 [TBL] [Abstract][Full Text] [Related]
9. Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study. Grinsztejn B; Hoagland B; Moreira RI; Kallas EG; Madruga JV; Goulart S; Leite IC; Freitas L; Martins LMS; Torres TS; Vasconcelos R; De Boni RB; Anderson PL; Liu A; Luz PM; Veloso VG; Lancet HIV; 2018 Mar; 5(3):e136-e145. PubMed ID: 29467098 [TBL] [Abstract][Full Text] [Related]
10. Willingness to Take PrEP and Potential for Risk Compensation Among Highly Sexually Active Gay and Bisexual Men. Grov C; Whitfield TH; Rendina HJ; Ventuneac A; Parsons JT AIDS Behav; 2015 Dec; 19(12):2234-44. PubMed ID: 25735243 [TBL] [Abstract][Full Text] [Related]
11. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study. Molina JM; Charreau I; Spire B; Cotte L; Chas J; Capitant C; Tremblay C; Rojas-Castro D; Cua E; Pasquet A; Bernaud C; Pintado C; Delaugerre C; Sagaon-Teyssier L; Mestre SL; Chidiac C; Pialoux G; Ponscarme D; Fonsart J; Thompson D; Wainberg MA; Doré V; Meyer L; Lancet HIV; 2017 Sep; 4(9):e402-e410. PubMed ID: 28747274 [TBL] [Abstract][Full Text] [Related]
12. "Sex without fear": exploring the psychosocial impact of oral HIV pre-exposure prophylaxis on gay men in England. Hayes R; Nutland W; Rayment M; Wayal S; Apea V; Clarke A; McOwan A; Sullivan A; Desai M; Jajja A; Rice B; Horne R; McCormack S; Gafos M AIDS Res Ther; 2023 Nov; 20(1):81. PubMed ID: 37964322 [TBL] [Abstract][Full Text] [Related]
13. Decentralizing the delivery of HIV pre-exposure prophylaxis (PrEP) through family physicians and sexual health clinic nurses: a dissemination and implementation study protocol. Sharma M; Chris A; Chan A; Knox DC; Wilton J; McEwen O; Mishra S; Grace D; Rogers T; Bayoumi AM; Maxwell J; Shahin R; Bogoch I; Gilbert M; Tan DHS BMC Health Serv Res; 2018 Jul; 18(1):513. PubMed ID: 29970087 [TBL] [Abstract][Full Text] [Related]
14. Sexual behavior and medication adherence in men who have sex with men participating in a pre-exposure prophylaxis study of combinations of Maraviroc, Tenofovir Disoproxil Fumarate and/or Emtricitabine (HPTN 069/ACTG 5305). Mayer KH; Yuhas K; Amico KR; Wilkin T; Landovitz RJ; Richardson P; Marzinke MA; Hendrix CW; Eshleman SH; Cottle LM; Marcus C; Chege W; Rinehart AR; Rooney JF; Andrew P; Salata RA; Magnus M; Farley JE; Liu AY; Frank I; Ho K; Santana J; Stekler JD; Chen YQ; McCauley M; Gulick RM; AIDS Behav; 2022 Dec; 26(12):4107-4114. PubMed ID: 35687192 [TBL] [Abstract][Full Text] [Related]
15. Effects of Pre-exposure Prophylaxis for the Prevention of Human Immunodeficiency Virus Infection on Sexual Risk Behavior in Men Who Have Sex With Men: A Systematic Review and Meta-analysis. Traeger MW; Schroeder SE; Wright EJ; Hellard ME; Cornelisse VJ; Doyle JS; Stoové MA Clin Infect Dis; 2018 Aug; 67(5):676-686. PubMed ID: 29509889 [TBL] [Abstract][Full Text] [Related]
16. Challenges and Opportunities for Preexposure Prophylaxis. Cambou MC; Landovitz RJ Top Antivir Med; 2021; 29(4):399-406. PubMed ID: 34856093 [TBL] [Abstract][Full Text] [Related]
17. The Pre-Exposure Prophylaxis-Stigma Paradox: Learning from Canada's First Wave of PrEP Users. Grace D; Jollimore J; MacPherson P; Strang MJP; Tan DHS AIDS Patient Care STDS; 2018 Jan; 32(1):24-30. PubMed ID: 29185801 [TBL] [Abstract][Full Text] [Related]
18. Pre-Exposure Prophylaxis (PrEP) for HIV Infection in Cisgender and Transgender Women in the U.S.: A Narrative Review of the Literature. Baldwin A; Light B; Allison WE Arch Sex Behav; 2021 May; 50(4):1713-1728. PubMed ID: 34075504 [TBL] [Abstract][Full Text] [Related]
19. HIV pre-exposure prophylaxis for men who have sex with men in west Africa: a multicountry demonstration study. Laurent C; Dembélé Keita B; Yaya I; Le Guicher G; Sagaon-Teyssier L; Agboyibor MK; Coulibaly A; Traoré I; Malan JB; De Baetselier I; Eubanks A; Riegel L; Rojas Castro D; Fayé-Ketté H; Koné A; Diandé S; Dagnra CA; Serrano L; Diallo F; Mensah E; Dah TTE; Anoma C; Vuylsteke B; Spire B; Lancet HIV; 2021 Jul; 8(7):e420-e428. PubMed ID: 34048794 [TBL] [Abstract][Full Text] [Related]
20. The effect of combination prevention strategies on HIV incidence among gay and bisexual men who have sex with men in the UK: a model-based analysis. Cambiano V; Miners A; Lampe FC; McCormack S; Gill ON; Hart G; Fenton KA; Cairns G; Thompson M; Delpech V; Rodger AJ; Phillips AN Lancet HIV; 2023 Nov; 10(11):e713-e722. PubMed ID: 37923485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]